Musculoskeletal adverse events induced by immune checkpoint inhibitors: a large-scale pharmacovigilance study

Conclusion: Immune checkpoint inhibitors administration triggers a range of musculoskeletal adverse events, warranting the optimization of their management during clinical practice.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research